Putin claims Russia has developed a coronavirus vaccine

Russian president says it's proven effective during tests, but skeptics note it hasn't gone through normal Phase 3 trials.

• Aug 12, 2020

Putin claims Russia has first COVID vaccine

Russian President Vladimir Putin claims his country is now using the world's first COVID-19 vaccine and one of his daughters has already been inoculated. Russian authorities say medical workers, teachers and others in high-risk groups will get the vaccine first. Dr. David Agus joins "CBS This Morning" to explain what we know about the vaccine and whether it changes how the U.S. and other countries approach vaccine development.

• Aug 11, 2020
• 01:55

Will a coronavirus vaccine help those who need it most?

There is a lack of trust between minority communities and the health care system, Dr. Uché Blackstock said.

• Aug 10, 2020

Getting a COVID vaccine to those at high risk

The United States hit yet another grim milestone in the coronavirus pandemic, with more than 5 million cases confirmed. Dr. Uché Blackstock joins CBSN to discuss the latest developments, including the push to get at-risk communities onboard with a vaccine.

• Aug 10, 2020
• 06:56

Tracking the latest with COVID-19

Tracking the latest: Questions remain as kids head back to school. CBS News medical contributor Dr. David Agus looks at the classroom, vaccines and more.

• Aug 8, 2020
• 02:58

Is a vaccine by Election Day possible?

President Trump says he is optimistic the U.S. could have a COVID-19 vaccine before November 3. Dr. David Agus joins "CBS This Morning" to discuss the likelihood there is a vaccine in the fall and address vaccine efficacy and safety concerns.

• Aug 7, 2020
• 04:51

Trump "optimistic" about a COVID-19 vaccine near Election Day

Public health experts, including Dr. Anthony Fauci, do not expect a vaccine to be available to the public before 2021.

• Aug 7, 2020

Companies race to develop COVID-19 monoclonal antibody treatment

In contrast to the convalescent plasma taken from survivors' blood, monoclonal antibodies can be manufactured in large amounts in a lab.

• Aug 5, 2020

W.H.O.: No "silver bullet" for COVID-19

The World Health Organization is warning the road to normalcy will be long and that there may never be a "silver bullet" for the novel coronavirus. Dr. Shoshana Ungerleider joins CBSN to discuss the latest developments, including an increase in the projected number of U.S. deaths, and why wearing a face shield isn't as good as wearing a mask.

• Aug 3, 2020
• 07:40

Goldman Sachs expects FDA-approved COVID-19 vaccine this year

Noting pace of research, investment bank says millions of Americans could get vaccinated by July of 2021.

• Aug 4, 2020

Doctor on COVID-19 treatments, school safety

The U.S. saw more than 67,000 new coronavirus cases Friday, pushing the total number of cases above 4.5 million. The death toll is now over 153,000. Dr. Amesh Adalja joins "CBS This Morning: Saturday" to discuss the state of testing, vaccines and school safety amid the pandemic.

• Aug 1, 2020
• 03:53

Sanofi, GlaxoSmithKline in $2.1 billion vaccine deal with U.S.

Federal funding will support vaccine development as well as manufacturing and delivery of 100 million doses.

• Jul 31, 2020

Moderna's phase 3 vaccine trial begins

The largest and final phase of a clinical trial to test Moderna's coronavirus vaccine in the U.S. has officially begun, as daily case numbers continue to rise in dozens of states. CBS News' Laura Podesta reports, and Dr. Ron Elfenbein joined CBSN to discuss the latest developments.

• Jul 27, 2020
• 10:39

Bill Gates on the handling of the coronavirus

The Bill and Melinda Gates Foundation focuses on public health and has committed more than $350 million for the development of vaccines, diagnostics and therapeutics in the fight against the coronavirus. Bill Gates joined "CBS Evening News" with more on the U.S.' pandemic response and the progress of finding a vaccine.

• Jul 22, 2020
• 03:22

NIH director on finding a vaccine for COVID-19

The National Institutes of Health is the nation's medical research agency and next week it will launch an unprecedented effort to help find a cure for COVID. NIH director Francis Collins joins "CBS Evening News" with more on "Operation Warp Speed," which aims to deliver 300 million doses of a coronavirus vaccine by January 2021.

• Jul 23, 2020
• 02:36

1,000+ U.S. COVID deaths 5 days in past week

Dr. Dyan Hes, a pediatrician in New York City, joins CBSN to discuss the latest coronavirus developments, including comments made by a former Obama health official outlining steps he says could curtail the pandemic in a matter of weeks.

• Jul 28, 2020
• 06:46

6 "types" of COVID, and impact of weather

Though some hoped summer heat and humidity would slow the spread of the coronavirus, U.S. cases keep rising. Dr. Bob Lahita joins CBSN to discuss that, plus a study by researchers in the U.K. that identifies six distinct "types" of COVID-19 cases.

• Jul 24, 2020
• 09:44

Final clinical trials on COVID-19 vaccines

Moderna and Pfizer are the first companies to enter Phase 3 clinical testing on a COVID-19 vaccine in the U.S. Each company plans to blind test 30,000 volunteers in hopes of having results and possibly effective vaccines by the end of the year. Meg Oliver reports.

• Jul 28, 2020
• 03:20

COVID-19 vaccine testing now underway with 30,000 volunteers

Every month through fall, the government-funded COVID-19 Prevention Network will roll out a new study of a leading vaccine candidate — each with 30,000 new volunteers.

• Jul 28, 2020

Virus vaccine trial shows promising results

The latest COVID-19 vaccine results show a strong immune response. Dr. Jon LaPook explains the next hurdles in the race to a vaccine.

• Jul 21, 2020
• 02:47

Oxford vaccine shows success in early trials

The COVID-19 vaccine being developed by researchers at the University of Oxford is considered one of the leading in the world, and researchers announced promising results of its first human trials. Charlie D'Agata reports on the vaccine that could provide a one-two punch against COVID-19.

• Jul 21, 2020
• 02:27

Oxford COVID-19 vaccine shows promise

Sunday marked the 41st straight day that the seven-day average for new daily coronavirus infections in the U.S. trended upward. CBS News' Laura Podesta reports on the latest developments and Dr. Ron Elfenbein joins CBSN to discuss a new study on the vaccine being developed by Oxford University, plus how face masks helped protect dozens of clients from getting infected at a hair salon in Missouri.

• Jul 20, 2020
• 11:08

Mask mandates continue to spark outrage as virus vaccine trials ramp up

While Planet Fitness joined the number of companies now requiring face coverings, nationwide the controversy won't go away.

• Jul 27, 2020

Fauci: "We could start talking about real normality again" in 2021

He made the remarks as the U.S. surpassed 4 million coronavirus cases.

• Jul 24, 2020

Millions of vials needed for COVID-19 vaccine

As scientists around the world race to develop a COVID-19 vaccine, there's also a scramble to make the millions of vials that would be necessary to deliver it. CBS's Weija Jiang takes us inside an Alabama factory that is going all out to meet a vital need, as part of the series Racing to a Cure.

• Jul 17, 2020
• 02:49

Show More